Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business
  • interests

Trending on Bing

Punch kills customer
Suspended for phone
'Turn page' on Trump
Took 38 years to find
Cause of death
Sauce under threat
White teachers go 1st
20,000 troops stranded
Kept split hidden
Court forcing birth
Push pin torture
Bed fall injury
First Lady gets COVID
Attacking swimmers
Lays off recruiters
CDC monkeypox warning
'Last call' announced
Reduction Act signed
Should've been woman?
14 FBI whistleblowers?
Password sharing gaffe
Resurrecting tiger
Season 5 trailer
484K SUVs recalled
Shark took part of leg
Oxygen from plasma
New action comedy
Drug raid recovery
Robotaxi live in Vegas
Pitches Xeomin fillers
Holiday seller fees
OTC hearing aids OK'd
Two-episode premiere
Alleged fraud schemes
Danger from ship noise
Moves into podcasting
WNBA Player of Year
Team for 'Wise Guys'
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
4,170 results
Omicron-Adapted Vaccine Delivery Expected in October, BioNTech Says
8, 2022 – BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October ... the company’s CEO and co-founder, said during the earnings call. BioNTech and Pfizer ...
WebMD8d
German vaccine developer BioNTech could deliver Omicron vaccines in October
CEO and Co-Founder of BioNTech. On hundred million vaccine doses of the Omicron booster based on the earlier BA.1 variant have already been pre-produced by BioNTech. The vaccine is currently ...
The Star8d
Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain
Pfizer and BioNTech said Friday that ... labeled the strain with the Greek letter omicron. In an emailed statement to FOX Business, Pfizer said the vaccine-makers are "remaining vigilant ...
Fox Business8mon
Pfizer CEO Albert Bourla tests positive for COVID-19 and is experiencing 'very mild symptoms'
"I am thankful to have received four doses of the Pfizer-BioNTech vaccine, and I am feeling well while experiencing very mild ...
WLWT
1d
UK clears new Moderna vaccine targeting Omicron variant
Half of the Moderna vaccine targets the original 2020 virus and half the Omicron variant, which is officially known as BA.1.
The Citizen
22h
Pfizer CEO tests positive for COVID
Pfizer CEO Albert Bourla on Monday disclosed that he has tested positive for COVID-19 and will be going into isolation while ...
YAHOO!News
1d
BioNTech’s Covid-19 vaccine boosts revenue to £8bn so far this year
In a call today, CEO Uğur Şahin said the results ... The company said it expects deliveries for its Omicron-adapted vaccine to begin as soon as October. BioNTech today outlined plans to launch ...
City A.M.8d
BioNTech Announces Second Quarter Financial Results and Corporate Update
Second quarter revenues of €3.2 billion1, net profit of €1.7 billion and fully diluted earnings per share of €6.45 ($6.872) as well as first half 2022 revenues of €9.6 billion, net profit ...
Yahoo News Australia8d
German vaccine developer BioNTech could deliver Omicron vaccines in October
German vaccine developer BioNTech could deliver its COVID-19 vaccines adapted to the Omicron BA.1 and BA.4/5 sub variants in October if given regulatory approval. Together with its U.S. partner Pfizer ...
Xinhua
8d
UK approves new Moderna vaccine targeting Omicron variant
LONDON: The UK's drug regulator said on Monday (Aug 15) it had approved an updated Moderna vaccine against the coronavirus ...
Channel NewsAsia Singapore
1d
BioNTech Announces Second Quarter Financial Results and Corporate Update
Second quarter revenues of €3.2 billion1, net profit of €1.7 billion and fully diluted earnings per share of €6.45 ($6.872) as well as first half 2022 revenues of €9.6 billion, net profit of €5.4 ...
Yahoo Finance8d
© 2022 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback